Richtlijn CVRM feb2013 - KNMP

Beune 2011 Beune EJ, Haafkens JA, Bindels PJ. Barriers and enablers in the implementation of a providerbased
intervention to stimulate culturally appropriate hypertension education. Patient Educ
2011; 82: 74-80.
Couns
Bikdeli 2011 Bikdeli B. C-reactieve protein, statins and the risk of vascular events: a better understanding.
Cardiovasc Drug Ther 2011; 25 (6): 545-9.
Binsbergen 2010 Binsbergen JJ van, Langens FNM, Dapper ALM, Halteren MM van, Glijsteen R, Cleyndert GA, al. NHGstandaard
Obesitas, M95. Huisarts Wet 2010: 53: 609-625.
Biondi 2011 Biondi-Zoccai G, Lotrionte M, Agostini P, Abbate A, Romagnoli E, Sangiorgi G, et al. Adjusted
indirect comparison meta-analysis of prasugrel versus ticagrelor for patient with acute
syndromes. Int J cardiol 2011; 150 (3): 325-31.
Black 2003
Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, et al. Principal results of the
Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003;
289: 2073-2082.
Bleckinsopp 2003 Bleckinsopp A, Anderson C en Armstrong M. Systematic review of the effectiveness of
community pharmacy-based interventions to reduce risk behaviours and risk factors for
coronary heart disease. J of Public Health 2003 (25; 2) 144-153.
Boden 2011 Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Kent M. et
al."Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N eng
2011; 365: 2255-2267.
J Med
Bodenheimer 2002 Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic
disease in primary care. JAMA 2002; 288: 2469-2475.
Bolland 2008 Bolland MJ, Barber PA, Doughty RN, et al. Vascular events in healthy older women receiving
calcium supplementation: randomised controlled trial. BMJ. 2008;336:262–266.
Bolland 2010 Bolland MJ, et al. Effect of calciumsupplements on risk of myocardial infarction and
cardiovascular events: meta-analysis. BMJ 2010; 341: c3691.
Bolland 2011
Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium supplements with or without vitamine D
and risk of cardiovascular events”reanalysis of the Women’s Health Initiative limited access dataset
and meta-anaysis. BMJ 2011; 342: d2040.
Bommel 2003 Van Bommel EFH. Zoutgevoeligheid en hypertensie. NTvG 2003; 147: 240-244
Bona 2011 Bona RD, De Caterina AR, Leo M, Biasillo G, Basile E, Cialdella P. Statins Reduce Incidence of
early peri operative complications and length of in-Hospital Stay afer coronary Artery Bypass
Surgery. J Clinic Experiment Cardiol 2011; 2: 137. Doi: 10.4172/2155-9880.1000137
Graft
Bonneux 2010
Bonneux L. “Het preventieconsult”. De health check van het Nederlands Huisartsen Genootschap.
Commentaar. NTvG 2011; 155: A3533.
Bos 2007 Bos H. Therapy resistance to the antiproteinuric and renoprotective efficacy of ACE inhibition.
Dissertation faculty of Medical sciences University of Groningen 2007. ISBN 9789075913545.
Brandt 2007 Brandt JT, Payne CD, Wiviott SD, et al. A comparison of prasugrel and clopidogrel loading doses
on platelet function: magnitude of platelet inhibition is related to active metabolite formation. Am
Heart J 2007 ; 153(1):66.e9-16.
Bray 2004 Bray GA, Vollmer WM, Sacks FM, et al. A further subgroup analysis of the effects of the DASH diet
and three dietary sodium levels on blood pressure: results of the DASH-sodium trial. Am J
Cardiol 2004; 94: 222-227.
Brenner 2001 Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH,et al. Effects of
losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and
nephropathy. N Engl J Med 2001; 345: 861-869.
Brewster 2004
Brewster LM, van Montfrans GA, Kleijnen J. Systematic review: antihypertensive drug therapy in
black patients. Ann Intern med 2004; 141: 614-627.
84
CONCEPT